AtlasXomics

Yes! Through Herm.io, you can unlock personalized AtlasXomics deals and exclusive rewards based on your shopping profile. Instead of the same generic discounts everyone gets, your profile shows AtlasXomics that you're a valuable shopper — and they respond with better offers. Sign up for free to see what exclusive rewards are available for you.

AtlasXomics offers products across the following categories: Services, Health Services. Browse their full range on their official website or explore exclusive offers for AtlasXomics products on Herm.io.

You can reach AtlasXomics through their official website at https://atlasxomics.com for support options.

Sign up for free on Herm.io, connect your shopping history, and follow AtlasXomics. Your shopping profile helps AtlasXomics see you're a valuable customer, unlocking personalized discounts, store credit, and exclusive merchandise. The more you engage and prove your loyalty, the better your rewards become.

AtlasXomics is a U.S.-based biotechnology company specializing in spatial epigenomics technology. They provide platforms and services for mapping chromatin accessibility, histone modifications, and DNA methylation across tissue architecture using their proprietary DBiT-seq methodology. Their products include spatial ATAC-seq, spatial CUT&Tag, and various kits and services primarily for research laboratories and biotech organizations.

AtlasXomics specializes in spatial epigenomics (chromatin accessibility, histone modifications, DNA methylation) while 10x Genomics is primarily known for spatial transcriptomics and gene expression. AtlasXomics offers unique epigenetic profiling capabilities that 10x doesn't focus on, including spatial ATAC-seq and CUT&Tag. Both operate in the premium tier, but AtlasXomics fills a different research niche focused on regulatory elements rather than just gene expression.

AtlasXomics serves both academic research laboratories and commercial facilities. They offer flexible options including full-service offerings where they run assays and deliver data, as well as kits for labs that want full execution control. Their target customers include university core facilities, genomics centers, neuroscience and oncology researchers, and clinical pathology labs.

AtlasXomics DBiT-seq focuses on spatial epigenomics (chromatin accessibility, histone marks, DNA methylation) while Resolve Biosciences specializes in spatial transcriptomics using molecular cartography. AtlasXomics is positioned as the first and only platform for high-resolution spatial epigenome mapping. Both are premium-tier platforms, but they address different aspects of spatial biology—AtlasXomics covers regulatory mechanisms while Resolve focuses on RNA expression.

Yes, AtlasXomics offers Spatial FFPE ATAC-seq specifically designed for archival formalin-fixed paraffin-embedded tissue. This allows researchers to perform single-cell chromatin accessibility mapping on preserved tissue samples, revealing spatial regulatory elements in archived specimens. This makes it valuable for retrospective studies and working with clinical biobank samples.

Spatial ATAC-seq maps open chromatin regions and chromatin accessibility across tissue, while Spatial CUT&Tag profiles specific histone modifications and marks on chromatin. Both provide spatial epigenomic information but target different regulatory features—ATAC-seq shows where chromatin is accessible, CUT&Tag shows specific histone marks.

While specific training details are not publicly listed, AtlasXomics provides platform kits designed for laboratories to execute spatial epigenomics experiments and offers AtlasVerify bulk qualification service to help labs validate their samples. Labs can also choose full-service options where AtlasXomics handles assay execution.

Yes, AtlasXomics specifically targets oncology researchers and their spatial epigenomics platforms are well-suited for mapping chromatin accessibility and regulatory elements within tumor tissue architecture. This enables researchers to understand spatial regulatory mechanisms in cancer tissues at single-cell resolution.

AtlasXomics is positioned as offering high-resolution spatial epigenome mapping using DBiT-seq technology. Specific resolution metrics are not publicly detailed, but the platform provides single-cell level chromatin profiling while maintaining spatial context across tissue architecture.

Turnaround time for AtlasXomics service offerings is not publicly specified and likely varies based on project complexity and sample type. Researchers should contact AtlasXomics directly to discuss timelines for their specific spatial epigenomics project needs.